Details for New Drug Application (NDA): 019795
✉ Email this page to a colleague
NDA 019795 describes CONDYLOX, which is a drug marketed by Allergan and Teva Branded Pharm and is included in two NDAs. It is available from two suppliers. Additional details are available on the CONDYLOX profile page.
The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
Summary for 019795
| Tradename: | CONDYLOX |
| Applicant: | Teva Branded Pharm |
| Ingredient: | podofilox |
| Patents: | 0 |
Suppliers and Packaging for NDA: 019795
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CONDYLOX | podofilox | SOLUTION;TOPICAL | 019795 | NDA AUTHORIZED GENERIC | Bryant Ranch Prepack | 63629-8832 | 63629-8832-1 | 3.5 mL in 1 BOTTLE, GLASS (63629-8832-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 0.5% | ||||
| Approval Date: | Dec 13, 1990 | TE: | AT | RLD: | Yes | ||||
Complete Access Available with Subscription
